These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: II. High sucrose-fed animals. Mukhopadhyay A, Patel ST, O'Brien M, Kokrady SS, Newman HA, Witiak DT, Lanese RR, Rice JC, Feller DR. Lipids; 1983 Jan; 18(1):59-67. PubMed ID: 6835036 [Abstract] [Full Text] [Related]
3. Synthesis of ethyl 6-substituted-chroman- and -chromone-2-carboxylates. A comparative structure-activity study employing the 6-phenyl and phenoxy analogs in the triton hyperlipidemic rat model. Witiak DT, Heilman WP, Sankarappa SK, Cavestri RC, Newman HA. J Med Chem; 1975 Sep; 18(9):935-42. PubMed ID: 1159716 [Abstract] [Full Text] [Related]
4. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate. Witiak DT, Newman HA, Poochikian GK, Fogt SW, Baldwin JR, Sober CL, Feller DR. J Med Chem; 1978 Aug; 21(8):833-7. PubMed ID: 99517 [Abstract] [Full Text] [Related]
5. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals. O'Brien M, Patel ST, Mukhopadhyay A, Newman HA, Feller DR, Kokrady SS, Witiak DT, Lanese RR, Rice JC. Lipids; 1981 Dec; 16(12):903-11. PubMed ID: 7329211 [Abstract] [Full Text] [Related]
11. Synthesis and pharmacological evaluation of cis-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-1-ones. Tricyclic analogues related to the antilipidemic drug clofibrate. Witiak DT, Loh W, Feller DR, Baldwin JR, Newman HA, Sober CL, Cavestri RC. J Med Chem; 1979 Jun; 22(6):699-705. PubMed ID: 110933 [Abstract] [Full Text] [Related]
12. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats. Kim SJ, Bok SH, Lee S, Kim HJ, Lee MK, Park YB, Choi MS. Toxicol Appl Pharmacol; 2005 Oct 01; 208(1):29-36. PubMed ID: 16164959 [Abstract] [Full Text] [Related]
17. Hypolipidemic activity of Phellinus rimosus against triton WR-1339 and high cholesterol diet induced hyperlipidemic rats. Rony KA, Ajith TA, Nima N, Janardhanan KK. Environ Toxicol Pharmacol; 2014 Mar 01; 37(2):482-92. PubMed ID: 24561532 [Abstract] [Full Text] [Related]
18. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice. Jiang C, Wang Q, Wei Y, Yao N, Wu Z, Ma Y, Lin Z, Zhao M, Che C, Yao X, Zhang J, Yin Z. J Ethnopharmacol; 2015 Dec 24; 176():17-26. PubMed ID: 26477373 [Abstract] [Full Text] [Related]
19. [Activities of 3-hydroxyl-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and the rate of mevalonic acid, squalene, sterol and fatty acid biosynthesis from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: effects of Triton WR 1339, starvation and cholesterol diet]. Poliakova ED, Dizhe EB, Klimova TA, Denisenko TV, Vasil'eva LE. Biokhimiia; 1981 Feb 24; 46(2):296-305. PubMed ID: 6113854 [Abstract] [Full Text] [Related]
20. [Studies on screening for cholesterol-lowering agents using phenyl- and chromane substituted compounds (author's transl)]. Yoshida K, Nakamura H. Hokkaido Igaku Zasshi; 1976 Nov 24; 51(6):513-8. PubMed ID: 1035574 [Abstract] [Full Text] [Related] Page: [Next] [New Search]